Elucidating the mechanism by which the antianginal ranolazine mitigates obesity-induced nonalcoholic fatty liver disease

• Author(s) / Creator(s)

  • Christina T. Saed
  • Rami Al Batran
  • Keshav Gopal
  • Amanda A. Greenwell
  • Farah Eaton
  • John R. Ussher

• Date created

  2019-12-20

• Subjects / Keywords

  • fatty liver disease
  • Obesity

• Type of Item

  Conference/Workshop Poster

• DOI

  https://doi.org/10.7939/r3-2cmd-bf95

• License

  Attribution-NonCommercial 4.0 International